Your search for comorbidities returned 228 results

A study was conducted to determine the safety of benzodiazepine therapy in patients with acute heart failure.

The cardioprotective effect was more pronounced with tadalafil than sildenafil.

A study was conducted to determine if early administration of dapagliflozin will improve cardiac function outcomes following anterior STEMI.

A study was conducted to determine if time-related changes in MECKI score can have additional prognostic value.

Researchers sought to describe the prevalence of VHD stages among older adults; determine the prognostic relevance of VHD stages for incidence CVDs; and characterize the progression in VHD stages over 6 years in late life.

Researchers sought to determine the relationship between urinary cGMP/BNP ratio and clinical outcomes in patients with heart failure with reduced ejection fraction.

Researchers sought to determine if catheter ablation better improves clinical outcomes compared with pharmacological therapy in patients with HF and AF.

Latest findings are from a post hoc meta-analysis of pooled data from the DAPA-HF and DELIVER trials.

A study was conducted to determine the prevalence of sudden cardiac death over 20 years in patients with heart failure in a Mediterranean cohort.

Researchers conducted a prospective cohort study to investigate the use of glimepiride in patients with type 2 diabetes and chronic heart failure.